HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
MBT-0312
Description
MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors.
No brand information found.
